New York State Common Retirement Fund’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-46,558
Closed -$3.17M 3291
2022
Q3
$3.17M Buy
46,558
+1,611
+4% +$88.8K ﹤0.01% 1379
2022
Q2
$1.44M Buy
44,947
+1,395
+3% +$40.8K ﹤0.01% 1837
2022
Q1
$1.51M Buy
43,552
+482
+1% +$14.4K ﹤0.01% 1895
2021
Q4
$1.26M Sell
43,070
-144
-0.3% -$4.46K ﹤0.01% 2019
2021
Q3
$1.1M Sell
43,214
-8,386
-16% -$246K ﹤0.01% 2071
2021
Q2
$1.81M Sell
51,600
-13,200
-20% -$515K ﹤0.01% 1932
2021
Q1
$2.64M Sell
64,800
-11,000
-15% -$506K ﹤0.01% 1617
2020
Q4
$3.28M Sell
75,800
-17,426
-19% -$859K ﹤0.01% 1433
2020
Q3
$5.14M Buy
93,226
+600
+0.6% +$38.1K 0.01% 1150
2020
Q2
$5.85M Buy
92,626
+32,467
+54% +$2.23M 0.01% 1098
2020
Q1
$3.07M Sell
60,159
-983
-2% -$65.8K ﹤0.01% 1240
2019
Q4
$4.86M Sell
61,142
-4,785
-7% -$284K 0.01% 1265
2019
Q3
$3.2M Buy
65,927
+459
+0.7% +$23.9K ﹤0.01% 1416
2019
Q2
$3.44M Buy
65,468
+4,500
+7% +$259K ﹤0.01% 1406
2019
Q1
$3.23M Buy
60,968
+11,968
+24% +$588K ﹤0.01% 1407
2018
Q4
$2.01M Sell
49,000
-12,478
-20% -$468K ﹤0.01% 1551
2018
Q3
$2.34M Hold
61,478
﹤0.01% 1597
2018
Q2
$2.78M Buy
61,478
+13,720
+29% +$625K ﹤0.01% 1508
2018
Q1
$2.31M Buy
47,758
+2,000
+4% +$112K ﹤0.01% 1549
2017
Q4
$1.8M Buy
45,758
+6,258
+16% +$234K ﹤0.01% 1703
2017
Q3
$1.23M Hold
39,500
﹤0.01% 1905
2017
Q2
$1.08M Buy
39,500
+20,012
+103% +$595K ﹤0.01% 1997
2017
Q1
$718K Sell
19,488
-712
-4% -$17.9K ﹤0.01% 2201
2016
Q4
$292K Hold
20,200
﹤0.01% 2625
2016
Q3
$466K Buy
20,200
+5,800
+40% +$111K ﹤0.01% 2348
2016
Q2
$239K Buy
14,400
+7,200
+100% +$145K ﹤0.01% 2648
2016
Q1
$114K Hold
7,200
﹤0.01% 2891
2015
Q4
$233K Buy
+7,200
New +$312K ﹤0.01% 2690

Other funds holding GBT

New York State Common Retirement Fund's GBT Position: Q4 2022 in Review

New York State Common Retirement Fund sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 46,558 shares — an estimated $3.17M sold.

New York State Common Retirement Fund first reported a position in GBT in Q4 2015 and held it in 28 quarters. The position peaked at $5.85M in Q2 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • New York State Common Retirement Fund reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 46,558 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.17M.
  • New York State Common Retirement Fund first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 28 quarters.
  • New York State Common Retirement Fund's Global Blood Therapeutics, Inc. position peaked at $5.85M in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on New York State Common Retirement Fund's 13F filing for Q4 2022, filed 30 Jan 2023.